To keep up with the latest news in real-time, subscribe to our email alerts, and follow us on Twitter, Facebook and LinkedIn. If you are a reporter and have questions about the company, please contact us

Latest News


Jun 4, 2018

Merck KGaA, Darmstadt, Germany, today announced results from expansion cohorts of the ongoing M7824 Phase I clinical trial (NCT02517398) program at the American Society of Clinical Oncology 2018.

Jun 4, 2018

ASCO Abstract # Avelumab: 9507, 9537 Two-year follow-up data on meaningful durable responses, overall survival (OS) and progression-free survival (PFS) to be presented in patients with metastatic...

Jun 3, 2018

Not intended for UK-based media Data from an ongoing Phase II tepotinib study show anti-tumor clinical activity in patients with advanced non-small cell lung cancer harboring MET exon 14 skipping...

May 30, 2018

Darmstadt, Germany, May 30, 2018 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced its support of World MS Day 2018 and MS International Federation...

  All Press Releases

In the News


No items to display.

  All In the News